ganirelix acetate

FDA Drug Profile — Fyremadel

Drug Details

Generic Name
ganirelix acetate
Brand Names
Fyremadel
Application Number
ANDA204246
Sponsor
Ferring Pharmaceuticals Inc.
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
GANIRELIX ACETATE

Indications and Usage

INDICATIONS AND USAGE Ganirelix acetate injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.

Warnings

WARNINGS Ganirelix acetate injection should be prescribed by physicians who are experienced in infertility treatment. Before starting treatment with ganirelix acetate, pregnancy must be excluded. Safe use of ganirelix acetate during pregnancy has not been established (see CONTRAINDICATIONS and PRECAUTIONS ).